TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. has unveiled a comprehensive solution to streamline contract manufacturing of various test kits, including in vitro diagnostics. The move aims to bolster in-house processes by minimizing reliance on external outsourcing, thus reducing costs and production times.
The company has traditionally handled development, manufacturing, and bulk production of extraction buffers. Recently, it established dedicated production lines for the dispensing and packaging of these buffers, enabling TANAKA to manage the entire process from development to the final product in-house. This development reportedly leads to faster delivery times and enhanced product quality.
TANAKA plans to further enhance production capacity through the integration of advanced automatic assembly lines and extract dispensing equipment by March 2026. This expansion is expected to further reduce lead times and improve operational flexibility.
The integrated production system offers a versatile response, allowing the company to manage comprehensive contract services across all stages of test kit production. Additionally, it accommodates requests for individual processes like extraction buffer dispensing alone while maintaining high standards in supply stability and quality control.
The company's test kits are designed to detect a range of diseases, including respiratory infections such as influenza, COVID-19, and mosquito-borne diseases like dengue and ZIKA viruses. These kits support various sample types and provide swift, accurate testing capabilities.
With a history of pursuing in vitro diagnostics since 2006, TANAKA has developed expertise in technologies related to nano-colloidal gold. The company leverages its proprietary technologies for enhancing reagent performance to offer high-quality test kits in line with ISO 13485 standards.
TANAKA intends to collaborate with partner companies to foster the development of new diagnostics. This strategic direction aligns with its mission to contribute to resolving social challenges and advancing medical science.